Bridgebio Oncology Therapeutics, Inc. (BBOT)

2.62 -0.08 (-2.96%) USD  |  NASDAQ  |  Oct 30, 16:00
2.64 +0.02 (+0.76%) After-Hours: 20:00
More

Bridgebio Oncology Therapeutics Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for BBOT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Stock Based Compensation (TTM) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
Date Value
June 30, 2025 --
March 31, 2025 --
December 31, 2024 --

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Korsana Biosciences, Inc. Upgrade
IRulya Therapeutics, Inc. Upgrade
PepGen Inc. Upgrade
Q32 Bio, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade